Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabor Hullam

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMC Neurology|October 17, 2019
Increased activation of the pregenual anterior cingulate cortex to citalopram challenge in migraine: an fMRI studyAndrea Edit Edes, Shane McKie, Edina Szabo, et al.
Scientific Reports|March 27, 2023
Genetic risk of depression is different in subgroups of dietary ratio of tryptophan to large neutral amino acidsBence Bruncsics, Gabor Hullam, Bence Bolgar, et al.
Journal of Medical Internet Research|June 24, 2024
Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation StudyRubèn González-Colom, Kangkana Mitra, Emili Vela, et al.
Plos One|March 10, 2015
Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressorsGabriella Juhasz, Xenia Gonda, Gabor Hullam, et al.
Neuropharmacology|October 9, 2019
Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI studyAndrea Edit Edes, Shane McKie, Edina Szabo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2025
Pharmacological profiling of major depressive disorder-related multimorbidity clustersTamas Nagy, Xenia Gonda, Andras Gezsi, et al.
Nature Communications|August 21, 2024
Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectoriesAndras Gezsi, Sandra Van der Auwera, Hannu Mäkinen, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMC Neurology|October 17, 2019
Increased activation of the pregenual anterior cingulate cortex to citalopram challenge in migraine: an fMRI studyAndrea Edit Edes, Shane McKie, Edina Szabo, et al.
Scientific Reports|March 27, 2023
Genetic risk of depression is different in subgroups of dietary ratio of tryptophan to large neutral amino acidsBence Bruncsics, Gabor Hullam, Bence Bolgar, et al.
Journal of Medical Internet Research|June 24, 2024
Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation StudyRubèn González-Colom, Kangkana Mitra, Emili Vela, et al.
Plos One|March 10, 2015
Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressorsGabriella Juhasz, Xenia Gonda, Gabor Hullam, et al.
Neuropharmacology|October 9, 2019
Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI studyAndrea Edit Edes, Shane McKie, Edina Szabo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2025
Pharmacological profiling of major depressive disorder-related multimorbidity clustersTamas Nagy, Xenia Gonda, Andras Gezsi, et al.
Nature Communications|August 21, 2024
Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectoriesAndras Gezsi, Sandra Van der Auwera, Hannu Mäkinen, et al.
Pageof 2